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Surgical outcome of degenerative versus
postreconstructive extracranial carotid artery
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Konstantinos P. Donas, MD, Stefan Schulte, MD, PhD, Georgios A. Pitoulias, MD, PhD,
Simone Siebertz, MD, and Svante Horsch, MD, PhD, Cologne, Germany
Objectives: Extracranial carotid artery aneurysms (ECAAs) are rare vascular lesions, and large series with short-term and
long-term outcomes are seldom reported. This study compared the clinical presentation and conventional treatment
outcomes of different ECAA types according to their etiology.
Methods: We retrospectively reviewed the data of 55 consecutive patients (47 men, 8 women) with 61 ECAAs who were
treated from January 1986 to December 2007 by conventional surgical techniques. The patients were a mean age of 65
11 years (range, 30-92 years). Thirty-two ECAAs (52.5%) occurred postoperatively after previous carotid endarterec-
tomy, of which 26 patients had 29 degenerative aneurysms (47.5%). Clinical presentation included cerebral stroke in
three patients (4.9%) and transient ischemic attack in 26 (42.7%). Mean follow-up was 42.7  22.0 months. Statistical
analysis was performed within and between degenerative and post-reconstructive ECAA subgroups of patients.
Results: Open aneurysm resection included 27 extended polytetrafluoroethylene interposition grafts, 12 venous grafts,
and 22 closures using synthetic patch. Cumulative 1-year primary patency rates were 86.9% for the degenerative ECAAs
and 96% for the postoperative ECAAs, with respective secondary patency rate at 5 years of 80% and 93.3%. The 5-year
patency rate was 88.9% for synthetic grafts compared with 66.7% for vein grafts and 86.4% for synthetic patches. These
differences were not statistically significant (P > .05). Complications for the degenerative ECAAs included two
reconstruction thromboses <30 days, two cerebral strokes, and one myocardial infarction. The patients with postoper-
ative ECAAs experienced one early thrombosis and two strokes postoperatively. Two patients (3.6%) from the
degenerative ECAA subgroup died of cardiac decompensation (n  1) and cerebral ischemic event (n  1).
Conclusions: Despite the different trends, no significant differences were found between degenerative ECAA and
postoperative ECAA patients in clinical presentation, localization, and surgery outcomes. The good middle-term and
long-term patency rates of synthetic graft reconstruction justify its use in the treatment of ECAAs, and it is less time
consuming and technically demanding compared with vein interposition graft. ( J Vasc Surg 2009;49:93-8.)Extracranial carotid artery aneurysms (ECAAs) are
quite rare lesions that count for 1% of all peripheral
aneurysms and 1.5% of all carotid procedures.1 Athero-
sclerosis is the most common reported etiologic factor for
the formation of a true and usually fusiform-shaped ECAA.
In contemporary series, nearly 50% of the reported cases
were false aneurysms of the ECA that occurred after carotid
endarterectomy (CEA) and patching.1 Rare causes of
ECAA include arterial dysplasia, dissection, blunt or pene-
trating trauma, connective tissue disorders, and a previous
mycotic infection.1-3
The goal of the present study was the retrospective
analysis of prospectively collected data of 61 ECAAs that
were treated by conventional surgical techniques during
a 22-year period. A further aim of our investigation was
the detection of possible differences in clinical features,
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PATIENTS AND METHODS
Between January 1986 and December 2007, 9567
carotid procedures were performed in our department for
treatment of carotid occlusive disease. Data from these
procedures were collected prospectively and were analyzed
retrospectively for this study. The following procedures
were performed: 5549 eversion CEAs (58%), 2918 CEAs
(30.5%) with synthetic patch closure, of which 2099 were
with expanded polytetrafluoroethylene (ePTFE) and 604
with Dacron; 602 CEAs (6.3%) with venous patch closure;
and 325 CEAs (3.4%) with primary closure. Finally, 172
patients (1.8%) underwent carotid artery stenting as the
primary treatment.
During the study period, 55 patients (47 men and 8
women; male/female ratio, 5.8:1) with 61 ECAAs were
diagnosed and treated surgically. An anastomotic pseudo-
aneurysm developed in 29 patients (52.5%) after previous
carotid surgery (pECAA) that was performed in our insti-
tution. Twenty-six patients had 29 dECAA (47.5%). The
mean age of the patients was 65  11 years (range, 30-92
years). Three patients had bilateral dECAAs, and another
three had bilateral pECAAs. Table I summarizes the
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The pECAAs occurred in 43.4% after venous patching
(14 patients in 602 procedures), 34.4% after eversion CEA
(11 of 5549), and 22.2% after operative treatment of severe
carotid stenosis by synthetic patching (7 of 2918). The
mean period during which anastomotic pseudoaneurysms
developed was 49.5  4.0 months after the previous ca-
rotid surgery using vein patching and 34.5  3.1 months
after eversion CEA. The mean time period for the develop-
ment of pECAAs after previous carotid restoration of blood
flow by synthetic patching was 39  2.9 months.
The definition of ECAA was based on the maximum
vessel diameter using measurements from duplex ultra-
sound (DUS) imaging and computed tomography (CT)
scanning. Patients with vessel dilatation 150% of the
common carotid artery diameter or 200% of the internal
carotid artery diameter were diagnosed as having an
ECAA.4,5 In asymptomatic patients or in small ECAAs with
a diameter 20 mm, the presence of intraluminal throm-
bus in the aneurysm sack ensured the diagnosis of ECAA
and the need for surgical treatment to avoid cerebral
thromboembolism. Mean diameters were 23.9 7.2 mm
for dECAAs and 22.1  3.7 mm for pECAAs.
Clinical presentation of the ECAAs included cerebral
stroke in three patients (5.4%), transient ischemic attack
(TIA) in 26 (47.3%), a palpable pulsatile mass of the neck in
18 patients (32.7%), difficulty swallowing in four (6.0%),
and aneurysm rupture in two (2.7%). Finally, 21 patients
(32.4%) were asymptomatic. Aneurysm morphology was
saccular in 27 ECAAs (44.3%) and fusiform shaped in 34
(57.3%). The clinical presentation and diagnosis data of the
two ECAA subgroups are compiled in Table II.
All patients were treated with conventional techniques
under general endotracheal anesthesia. Intraoperative cere-
Table I. Patient demographics and cardiovascular risk
factors
Variable pECAA dECAA Pa
Demographics
Age, mean  SD, y 65.1 11.2 61.1 4.2 .654
Male/female ratio 5.4:1 4.1:2 .343
Risk factors, No. (%)
Hypertension 25 (61.0) 16 (39.0) .432
Dyslipidemia 10 (41.7) 14 (58.3) .234
Smoking 12 (60.0) 8 (40.0) .321
Diabetes mellitus 5 (62.5) 3 (37.5) .345
Coronary artery disease 12 (36.4) 21 (63.6) .332
PAOD 17 (63.0) 10 (37.0) .232
Aneurysm in another
locationb 3 (33.3) 7 (63.7) .234
dECAA,Degenerative extracranial carotid artery aneurysm; PAOD, periph-
eral arterial occlusive disease; pECAA, post-reconstructive extracranial ca-
rotid artery aneurysm; SD, standard deviation.
aNo significant differences (P .05) between the two subgroups in terms of
demographic features (P  .05 is significant.)
bPopliteal, aortic, or iliac artery.bral monitoring included transcranial Doppler imaging,somatosensory evoked potentials (SSEP), and measure-
ment of regional brain tissue oxygen saturation (rSO2) by
near-infrared spectroscopy. The simultaneous reduction of
rSO2 was 55% in all patients. In 39 ECAA (63.9%) that
were fusiform shaped or saccular with large neck, the pref-
erable treatment option was aneurysm resection and the
continuation of cerebral flow by interposition graft (PTFE
in 27 and venous graft from saphenous vein in 12). In
saccular ECAAs with narrow necks, the resection was done
using synthetic patch (PTFE in 16; Dacron in 6). In addi-
tion, in 23 ECAAs (37.7%; 8 degenerative and 15 post-
reconstructive) ligation of the external carotid artery was
necessary before restoration of cerebral flow. Nine patients
(16.4%) underwent operations with intraluminal shunting,
without any perioperative neurologic deficit.
To be more precise with the preoperative clinical man-
ifestation of the aneurysms, we classified the cerebrovascu-
lar insufficiency in following stages:
● Stage I: asymptomatic vascular insufficiency;
● Stage II: spontaneously reversible ischemic symptoms;
● Stage III: prolonged ischemia (stroke in evolution),
and
● Stage IV: irreversible cerebrovascular ischemic dam-
age, such as stroke
Microbiologic culture analysis did not reveal a specific
microorganism in any of the exampled specimens nor in the
two aneurysms that ruptured. However, the macroscopic
appearance and histologic analysis showed significant data.
Specimens from atherosclerotic aneurysms had typical evi-
dence of atherosclerosis, with intimal and medial degener-
ation/disruption. Specimens from post-reconstructive an-
eurysms had evidence related to the primary carotid
procedure and the ECAAs morphology. No evidence of
fibromuscular dysplasia was detected.
Mean follow-up was 42.7 22.0 months and included
DUS scans at 1, 3, 6, and 12 months, and yearly thereafter,
as well as an independent postoperative neurologic exami-
nation before the patient was discharged and in any cere-
bral event that was diagnosed during the entire follow-
up period.
Statistical analysis was performed within groups and
between atherosclerotic and post-reconstructive ECAA pa-
tients, using SPSS software (SPSS Inc, Chicago, Ill). Con-
tinuous data were compared using the t test and categoric
variables with the Fisher exact test, as appropriate. The
1- and 5-year primary and secondary patency rates for
patients of the two groups with immediate (30-day) suc-
cessful outcomes were estimated using Kaplan-Meier life-
table analysis. The same analysis was used to compare the
early- and long-term primary patency rates between the
three different types of ECAA reconstruction techniques
(PTFE graft vs venous graft vs synthetic patch)
RESULTS
Morbidity. Three patients presented with permanent
cerebral stroke, two from the dECAA subgroup due to
early thrombosis of the reconstruction (1 vein graft; 1
ation
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cerebral thromboembolism. One patient sustained a myo-
cardial infarction on postoperative day 5, and another pa-
tient died because of fatal cardiac decompensation.
For the pECAA subgroup, cerebral stroke was noted in
two of 29 patients due to early reconstruction thrombosis
in one patient (vein graft) and because of clamping intol-
erance in the other, having no evidence of a thromboem-
bolism event based on the angiography postoperatively and
Fig 1. Cumulative primary patency rates at 5-years for degenera-
tive (dECAA, broken line) and postoperative (pECAA, solid line)
extracranial carotid aneurysms.
Table II. Clinical presentation and diagnostic data of the
Variable dECCA (n 
Symptoms, No. (%)
Asymptomatic 9 (31.1)
Transient ischemic attack 10 (34.5)
Stroke 1 (3.4)
Pulsatile masse 9 (31.1)
Swallowing difficulties 3 (10.3)
Rupture 1 (3.4)
Other not specific symptoms 7 (24.1)
Localization, No. (%)
Right side 14 (48.3)
Left sidea 15 (51.7)
Bilateral 3 (10.3)
Common carotid 4 (13.8)
Internal carotid 14 (48.3)
Entire bifurcation (3 vessels) 11 (37.9)
Morphology
Sacculara, No. (%) 9 (31.1)
Diameter, mean (SD), mm 24.9  1.9 (7
Fusiform, No. (%) 20 (68.9)
Diameter, mean (SD), mm 23.4  1.2 (7
CVI stage, No. (%)
Stage I 18 (62.1)
Stage II 8 (27.6)
Stage III 2 (6.9)
Stage IV 1 (3.4)
CVI, Cerebrovascular insufficiency stage; dECAA, degenerative extracrania
aneurysm; SD, standard deviation.
aDifferences between two groups were significant in left vs right side localizsignificant changes in the intraoperative neuromonitoring.In addition, one patient experienced an episode of pro-
longed reversible ischemic neurologic deficit with con-
tralateral arm paresis.
In 61operations, cranial nerve injuries resulting in pa-
resis of recurrent laryngeal nerve occurred in six patients
(transient in 3), and three patients had a transient paresis of
the hypoglossal nerve. Cranial nerve deficits, such as
hoarseness, dysphagia, andHorner syndrome, were present
in six patients. Respiratory complications included pneu-
monia in one patient in both groups.
Mortality. Two patients from the dECAA group died,
one each of cardiac decompensation and because of stroke
after early thrombosis and revision surgery. The overall
mortality for the 55 patients with 61 ECAA open recon-
structions was 3.6%.
Patency. The 1-year primary patency rates were 86.9%
for dECAA patients and 92.8% for pECAA patients, and
the respective secondary patency rates were 95.6% and
100%. The 5-year primary patency rates were 80% for the
dECAA group and 93.3% for the pECAA group, and the
respective secondary patency rates were 93.3% and 100%.
Fig 1 shows the 5-year primary patency rates according to
whether the ECAAs were postoperative or degenerative.
The patency rates of the different types of reconstruc-
tion (vein graft, synthetic graft, and synthetic patch) during
a 5-year period are shown in Fig 2. The early (30-day)
patency rates were 96.3% for synthetic grafts, 83.3% for vein
grafts, and 95.5% for and synthetic patching. A sustained
xtracranial carotid artery aneurysms
pECCA (n  32) P
12 (37.6) .232
16 (50) .122
2 (6.2) .223
9 (28.1) .123
1 (3.1) .234
1 (3.1) .234
9 (28.1) .345
9 (28.1) .321
23 (71.9) .023
3 (9.3) .342
5 (15.6) .223
12 (37.5) .145
15 (46.9) .123
18 (56.2) 031
22.9  1.7 (4.0) .334
14 (43.8) .113
21.1  1.7 (3.2) .234
14 (43.8) .233
14 (43.8) .342
2 (6.2) .234
2 (6.2) .243
id artery aneurysm; pECAA, post-reconstructive extracranial carotid artery
(P  .023) and saccular vs fusiform morphology (P  .031).61 e
29)
.1)
.3)
l carotgood patency rate of 88.9% for the synthetic grafts was
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the patency rate for synthetic patching was slightly inferior,
at 90.9% and 86.4%, and for the vein grafts, 66.7%. These
differences were not statistically significant (P  .05).
Fusiform-shaped aneurysms were more frequent in ve-
nous patch and eversion CEA cases, and saccular ECAAs
were usually located in the medial or lateral suture line of a
synthetic patch or of an eversion CEA closure. Fusiform-
shaped aneurysms had histologic evidence of intimal fibro-
sis and sclerosis, disruption of elastic and muscular fibers,
and wall dissection. Examination of saccular ECAAs re-
vealed chronic inflammatory response due to foreign body
reaction with foam cells and histiocytosis. Finally, in venous
patch cases, the main evidence was sclerosis and degenera-
tion of the venous wall.
Statistical analysis did not reveal any significant differ-
ence between dECAA and pECAA patients for the etiology
and size, the clinical presentation, and cerebrovascular in-
sufficiency stage status, or in the immediate, 1-year, and
5-year outcomes. The difference between two groups was
significant only in morphology. The incidence of saccular
ECAAs (56.2%) was higher in the pECAA group and
fusiform shaped (68.9%) in the dECAA group. In addition,
a within-group analysis showed a difference between post-
reconstructive patients in localization in favor of the left
side (Table II, P  .023) and in the type of primary
operation (venous patch vs other types, P .05, Table II).
DISCUSSION
ECAAs are rare vascular lesions that account for ap-
proximately 1% of all carotid operations performed at major
vascular centers.1 Primary ECAA are classified as either
fusiform or saccular. Fusiform lesions are usually degener-
ative, have a bilateral predilection, and occur at the carotid
bifurcation. The saccular type is usually unilateral and
mostly located in themiddle segment of the internal carotid
artery.
Atherosclerosis remains the main cause of all ECAAs.
Fig 2. Cumulative primary patency rates of the three techniques
of reconstructions—synthetic patch (solid line), polytetrafluoro-
ethylene (PTFE) graft (small broken line), and venous graft (large
broken line)—during a 5-year period.Numerous reports have published different causes for thedevelopment of true ECAAs, such as infection, inflamma-
tion, fibromuscular dysplasia, cystic necrosis of media,
Behçet-Adamantiades disease, protein C and S and anti-
thrombin III deficiency, and idiopathic medial arterio-
pathy.2-4 Radak et al5 reported that tuberculous lymphad-
enitis of the neck was underlying cause for ruptured ECAA.
Four groups of false aneurysms have been reported:
traumatic, anastomotic developing after previous carotid
surgery, iatrogenic, and dissecting.5 False traumatic ECAAs
are caused by blunt trauma of the neck.6 Possible explana-
tions for this may be extreme hypertension, twisting of the
neck, and mandibular fractures.7 Anastomotic pseudoan-
eurysms are thought to be more common after CEA with
patching than after CEA alone.5 Iatrogenic carotid
pseudoaneurysms occur after various surgical procedures in
the neck. Dissecting ECAAs are rare and are caused by
spontaneous carotid dissection.5
The present study reports one of the largest series in the
literature of surgery of ECAA, with equal number of pa-
tients with dECAAs (47.5%) and pECAAs (52.5%). We
have reviewed in Table III1-16 the largest series during the
last 15 years that present complete data of the number of
the treated aneurysms, the length of follow-up, and the
immediate adverse events and death rat.
The subgroup analysis of the pECAAs and dECAAs
showed an apparent predominance of the pECAAs in the
clinical manifestation with a neurologic event (43.8% vs
27.6%, P  .05). Almost 72% of pECAAs vs 51.7% of
dECAAs occurred at the left side. One possible explanation
may be the greater length of the left internal carotid artery
and its predisposition to kinking and torsion with subinti-
mal tearing requiring extensive and technically more de-
manding arteriotomy.7 Further investigation in this issue is
necessary. One other difference between the two sub-
groups was the morphology of the aneurysms: 64.6% of the
dECCAs were fusiform compared with the pECAAs, which
had 50% fusiform and 46.8% saccular.
The most common first manifestation of the ECAA is a
TIA, which occurred in approximately 60% of the patients.
In our series, the aneurysms had a varied clinical presenta-
tion. The pulsatile neckmass caused difficulty in swallowing
in 14 patients (25.4%). Neurologic manifestations were
noted in 29 of 55 patients (52.7%) in the form of TIA (n
26) or hemispheric brain ischemia (n  3) and were the
leading symptom.
Surgical treatment aims to eliminate the aneurysm and
restore arterial continuity. In small, elongated ECAAs,
resection and direct end-to-end anastomosis is feasible.
Other possible techniques with satisfactory results are re-
placement or interposition by a vein graft or the use of
synthetics grafts. Bakoyannis et al16 recommend an ex-
tended cervical incision to approach large and high-lying
aneurysms above the Blaisdell line (an imaginary line con-
necting the mastoid to the angle of the mandible) and even
construction of a distal anastomosis into the carotid fora-
men. For longer distances, other approaches, such as cervical-
petrous, posterior-lateral, and anterior-lateral are more
suitable.
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to treat 63.9% of the patients in our series. Saphenous vein
interposition was used in 12 of 61. In contrast with the
recommendation of many authors that synthetic graft re-
main the second choice if appropriate saphenous vein is
unavailable, we recorded a primary patency rate of 88.9%
during a 5-year period. The sustained good patency rate of
the PTFE reconstructions should ensure the use of syn-
thetic material as the first choice for the reconstruction
owing to less time duration and challenge compared with
the vein interposition graft.
Whereas a long vein graft in the extremities accommo-
dates to this additional length by assuming a gentle curve in
the thigh, a short vein graft as in the case of carotid
procedures instead tends to kink within the tight confines
of the neck. It tends to elongate as well as dilate once flow
has been restored. Therefore, a carotid interposition vein
graft must be trimmed precisely to its estimated postperfu-
sion length before the final anastomosis is completed. This
may explain the apparent inferior patency rate of the vein
interposition grafts in our series, especially as Fig 2 suggests
the occlusions of these grafts during the early postoperative
period. Another reason may be the smaller number of
patients who were treated by this type of reconstruction.
Whether to use an intraluminal shunt during the aneu-
rysm repair remains controversial. Difficulties in its place-
ment into the artery and its use can lead to distal emboli-
zation and cerebral events. We performed continuous
neurophysiologic monitoring by measuring the short la-
tency SSEP, rSO2 by near-infrared spectroscopy, and trans-
cranial DUS during the operation. The simultaneous re-
duction of rSO2 55% and great changes in SSEP
amplitude, or history of ipsilateral stroke or contralateral
occlusive lesions were absolute indications to use an intralu-
minal shunt.
The literature provides for the moment scant informa-
tion concerning endovascular techniques in the treatment
Table III. Review of the largest series regarding a surgica
carotid artery
First author Year Aneurysms, No. Patients, No
Moreau8 1994 38 35
Schievink9 1994 22 22
Liapis10 1994 12 12
Faggioli11 1996 24 20
Pulli12 1997 21 21
Zhang13 1999 66 63
Rosset3 2000 25 25
El-Sabrout2 2000 65 NA
Alberti14 2002 19 17
Davidovic15 2004 17 16
Bakoyannis16 2006 10 9
Radak5 2007 91 76
This study 2008 64 58
NA, Not available.
aEarly postoperative myocardial infarction and stroke.of ECAAs. Bergeron et al17 reported that covered stentsand endografts offer a new therapeutic option for ECAAs,
excluding nerve injury from procedural complications.4
They treated five ECAAs endovascularly, and no in-hospital
complications or adverse events were observed during a
follow-up period of 3.6 1.3 years. The stents were patent
without evidence of in-stent stenosis. Severe complications
have also been reported, however, such as recoil or deform-
ing of the prosthesis.18 It is important to mention that
first-generation stent grafts were used, which tended to
have device-related complications.
CONCLUSION
ECAAs produce a high incidence of severe neurologic
deficits. This condition justifies an aggressive surgical ap-
proach to restore the arterial continuity. The primary rate
of cumulative major adverse cardiovascular events, includ-
ing stroke, myocardial infarction, and death, of the entire
series was 9.3%. Nevertheless, the operative treatment of
these lesions is technically demanding and strongly related
to a high risk of cranial nerve injuries and neurologic events.
Reliable alternatives are needed to simplify the challenging
surgical approach, such as the use of synthetic grafts as first
line reconstruction type.
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